Revelation Biosciences Company Insiders
| REVBW Stock | USD 0.01 0 16.50% |
Revelation Biosciences employs about 9 people. The company is managed by 4 executives with a total tenure of roughly 21 years, averaging almost 5.0 years of service per executive, having 2.25 employees per reported executive. Recap of Revelation Biosciences' management performance can provide insight into the venture performance.
Revelation |
Revelation Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.5098) % which means that it has lost $0.5098 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7002) %, meaning that it generated substantial loss on money invested by shareholders. Revelation Biosciences' management efficiency ratios could be used to measure how well Revelation Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.01 in 2024. Return On Capital Employed is likely to climb to -1.24 in 2024. At this time, Revelation Biosciences' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 198.9 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 61.8 K in 2024.Common Stock Shares Outstanding is likely to climb to about 240.1 K in 2024
Revelation Biosciences Workforce Comparison
Revelation Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 792. Revelation Biosciences claims roughly 9.0 in number of employees contributing just under 2% to equities under Health Care industry.
Revelation Biosciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Revelation Biosciences Price Series Summation is a cross summation of Revelation Biosciences price series and its benchmark/peer.
Revelation Biosciences Notable Stakeholders
A Revelation Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Revelation Biosciences often face trade-offs trying to please all of them. Revelation Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Revelation Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James Rolke | CEO Director | Profile | |
| Carol Odle | Director Projects | Profile | |
| Chester III | Chief Officer | Profile | |
| Sandra Vedrick | Vice Relations | Profile |
About Revelation Biosciences Management Performance
The success or failure of an entity such as Revelation Biosciences often depends on how effective the management is. Revelation Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Revelation management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Revelation management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (1.30) | (1.24) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.02) | (0.02) |
Please note, the imprecision that can be found in Revelation Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Revelation Biosciences. Check Revelation Biosciences' Beneish M Score to see the likelihood of Revelation Biosciences' management manipulating its earnings.
Revelation Biosciences Workforce Analysis
Traditionally, organizations such as Revelation Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Revelation Biosciences within its industry.Revelation Biosciences Manpower Efficiency
Return on Revelation Biosciences Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 13.4K | |
| Net Loss Per Executive | 30.1K | |
| Working Capital Per Employee | 731.4K | |
| Working Capital Per Executive | 1.6M |
Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.